A Study To Investigate The Absorption, Metabolism And Excretion Of [14C] PD 0200390 In Six Healthy Male Volunteers

Pfizer

Status and phase: Completed; Phase 1

Conditions: Insomnia

Treatments: Drug: PD 0200390

Study type: Interventional

Funder types: Industry

Identifiers

NCT00722306

A4251072

Details and patient eligibility

About

To determine the mass balance of PD 0200390

Enrollment: 6 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy

Exclusion criteria

• unhealthy, or concomitant meds

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

6 participants in 1 patient group

A425

Experimental group

Description:

A425 Treated

Treatment:

Drug: PD 0200390